Mylan Laboratories' Proposed Merger with King Pharmaceutical
通常価格
¥1,276 JPY
通常価格
セール価格
¥1,276 JPY
単価
あたり
Perry Capital owns shares in King and, to facilitate approval of the merger, buys shares in Mylan, whilst hedging out its economic exposure to Mylan's share price using derivatives. The price at which Mylan proposes to merge with King is generous to King shareholders, but the merger does not look likely to be approved by Mylan shareholders, who must vote upon it. If Perry can swing the voting in favor of the deal, it will gain handsomely on its King shares without facing any corresponding losses on its Mylan holdings since those are hedged. Carl Icahn, another shareholder in Mylan, opposed the deal and sued Perry for alleged vote buying.
【書誌情報】
ページ数:17ページ
サイズ:A4
商品番号:HBSP-214078
発行日:2014/2/4
登録日:2016/8/8